CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings2,506 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

3.9M$2.4B5.4%$546.64+12.22%
5 qtrssince 2024-Q2
Increased
65
VEAVEA
ETF

VANGUARD FTSE DEVELOPED ETF

25M$1.4B3.2%$45.21+23.02%
27 qtrssince 2018-Q4
Increased
70

MICROSOFT CORP

2.6M$1.3B2.8%$282.69+74.82%
27 qtrssince 2018-Q4
Decreased
0

APPLE INC

6.1M$1.3B2.8%$149.33+36.73%
27 qtrssince 2018-Q4
Increased
55
VTVVTV
ETF

VANGUARD VALUE ETF

5.9M$1B2.3%$131.33+32.43%
27 qtrssince 2018-Q4
Increased
57
IEFIEF
ETF

ISHARES 7-10 YEAR TREASURY B

10M$956.9M2.1%$88.88+3.02%
27 qtrssince 2018-Q4
Increased
58
SHYSHY
ETF

ISHARES 1-3 YEAR TREASURY BO

10.7M$890.2M2.0%$75.62+5.02%
27 qtrssince 2018-Q4
Increased
53

NVIDIA CORP

5.6M$881.2M2.0%$114.70+37.52%
27 qtrssince 2018-Q4
Increased
52
AGGAGG
ETF

ISHARES TR

8.2M$812.6M1.8%$91.01+4.07%
5 qtrssince 2024-Q2
Increased
53
VOOVOO
ETF

VANGUARD S&P 500 ETF

1.2M$668.1M1.5%$449.83+24.94%
27 qtrssince 2018-Q4
Increased
55
VUGVUG
ETF

VANGUARD GROWTH ETF

1.5M$651.7M1.5%$49.90+45.80%
27 qtrssince 2018-Q4
Increased
52
MGKMGK
ETF

VANGUARD MEGA CAP GROWTH ETF

1.7M$611M1.4%$62.36+17.00%
22 qtrssince 2020-Q1
Increased
50
VBVB
ETF

VANGUARD SMALL-CAP VIPERS

2.4M$566M1.3%$205.63+14.28%
27 qtrssince 2018-Q4
Increased
52
BILBIL
ETF

SPDR BLOOMBERG 1-3 MONTH T-B

5.8M$530M1.2%$82.54+6.30%
27 qtrssince 2018-Q4
Increased
75

AMAZON.COM INC

2.4M$515.9M1.2%$136.94+63.07%
27 qtrssince 2018-Q4
Increased
52
IEMGIEMG
ETF

ISHARES CORE MSCI EMERGING

8.1M$488.7M1.1%$49.03+19.78%
27 qtrssince 2018-Q4
Increased
53
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

766,197$473.4M1.1%$408.93+49.51%
27 qtrssince 2018-Q4
Decreased
0
IXUSIXUS
ETF

ISHARES CORE INTL STOCK ETF

6M$467.4M1.0%$74.19+2.06%
21 qtrssince 2020-Q2
Increased
80
SCHXSCHX
ETF

SCHWAB US LARGE-CAP ETF

18.2M$445.1M1.0%$21.63+11.85%
27 qtrssince 2018-Q4
Increased
45
IEIIEI
ETF

ISHARES 3-7 YEAR TREASURY BO

3.7M$434.8M1.0%$111.50+2.39%
27 qtrssince 2018-Q4
Increased
46
$44.8B
AUM
2,506
Positions
Q2 2025
Filing
Rating · 5.0
Quarterly Portfolio Change
-6%Q1'24$27.2B+14%Q2'24$31.1B+8%Q3'24$33.7B+4%Q4'24$35B+14%Q1'25$39.9B+12%Q2'25$44.8B
Activity profile
$ moved · Q2'25
New2%Increased74%Decreased24%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.8 years
<1Q3%1-4Q5%1-2Y5%2Y+88%

CAPTRUST FINANCIAL ADVISORS manages $44.8B across 2506 positions as of Q2 2025. Top holdings: IVV (5.4%), VEA (3.2%), MSFT (2.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 5/5.0.

Q2 2025 Summary

Active quarter - 262 new positions, 107 exits, 1376 increased. Top move: IXUS (INCREASED, conviction 80). Portfolio: $44.8B across 2506 positions.

Top holdings by portfolio weight

Total AUM$45B
IVV5.37%
VEA3.18%
MSFT2.84%
AAPL2.80%
VTV2.31%
IEF2.13%
SHY1.99%
NVDA1.97%
AGG1.81%
VOO1.49%
Other1.45%

Portfolio allocation by GICS sector

Sectors11
Unknown53.95%
Technology14.23%
Financial Services7.75%
Healthcare4.66%
Industrials4.64%
Consumer Cyclical3.76%
Communication Services3.38%
Consumer Defensive2.72%
Energy1.69%
Basic Materials1.19%
Other2.04%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Elite(5.0 / 5.0)
Track Record61
Conviction41
Concentration40
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ABBVABBVABBVIE INC
Q3 2024 Q2 2026+649,630 shares+$257M
8Q
BCIBCIABRDN ETFS
Q3 2024 Q2 2026+36,409 shares+$867,503
8Q
ADPTADPTAdaptive Biotechnologies Corp.
Q3 2024 Q2 2026+12,146 shares+$462,243
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used